What is an appropriate intervention for a patient with multiple myeloma?

Adequate hydration is essential for patients with multiple myeloma, particularly because this condition can lead to various complications that affect kidney function. Multiple myeloma is characterized by an increase in the production of plasma cells, which can lead to the release of valuable proteins into the urine. This can create a risk for kidney damage, not only from the disease itself but also due to potential effects of treatments.

Maintaining proper hydration helps to dilute the proteins in the urine and supports kidney function, thereby reducing the risk of kidney injury. When patients are adequately hydrated, there is an improved urinary flow which helps in the excretion of harmful substances and prevents the accumulation of proteins in the kidneys.

This approach is quite different from other interventions. Complete bed rest at all times can lead to complications such as muscle atrophy and thromboembolism, which are not ideal for patient recovery. While pain management is important, frequent use of NSAIDs may pose risks such as gastrointestinal bleeding or further kidney injury, particularly in patients who are already at risk due to their condition. An increased high-protein diet may seem beneficial but can also contribute to strain on the kidneys if not monitored carefully, especially in the context of multiple myeloma where protein metabolism is altered.

Thus